Clinical Trial Update: Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China

View source ↗

Summary

A real-world study in China is evaluating the safety and effectiveness of IL-23 inhibitors for inflammatory bowel disease (Crohn's disease and ulcerative coliti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• IL-23 inhibitors

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | Status: NOT_YET_RECRUITING